377 related articles for article (PubMed ID: 12788569)
21. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.
Shindler DM; Kostis JB; Yusuf S; Quinones MA; Pitt B; Stewart D; Pinkett T; Ghali JK; Wilson AC
Am J Cardiol; 1996 May; 77(11):1017-20. PubMed ID: 8644628
[TBL] [Abstract][Full Text] [Related]
22. Racial differences in the outcome of left ventricular dysfunction.
Dries DL; Exner DV; Gersh BJ; Cooper HA; Carson PE; Domanski MJ
N Engl J Med; 1999 Feb; 340(8):609-16. PubMed ID: 10029645
[TBL] [Abstract][Full Text] [Related]
23. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
[TBL] [Abstract][Full Text] [Related]
24. The cost and cardioprotective effects of enalapril in hypertensive patients with left ventricular dysfunction.
Cook JR; Glick HA; Gerth W; Kinosian B; Kostis JB
Am J Hypertens; 1998 Dec; 11(12):1433-41. PubMed ID: 9880125
[TBL] [Abstract][Full Text] [Related]
25. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction.
Kostis JB
Am J Hypertens; 1995 Sep; 8(9):909-14. PubMed ID: 8541006
[TBL] [Abstract][Full Text] [Related]
26. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.
Konstam V; Salem D; Pouleur H; Kostis J; Gorkin L; Shumaker S; Mottard I; Woods P; Konstam MA; Yusuf S
Am J Cardiol; 1996 Oct; 78(8):890-5. PubMed ID: 8888661
[TBL] [Abstract][Full Text] [Related]
27. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators.
Kostis JB; Shelton B; Gosselin G; Goulet C; Hood WB; Kohn RM; Kubo SH; Schron E; Weiss MB; Willis PW; Young JB; Probstfield J
Am Heart J; 1996 Feb; 131(2):350-5. PubMed ID: 8579032
[TBL] [Abstract][Full Text] [Related]
28. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
McMurray JJ; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA;
Lancet; 2003 Sep; 362(9386):767-71. PubMed ID: 13678869
[TBL] [Abstract][Full Text] [Related]
29. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
Patten RD; Kronenberg MW; Benedict CR; Udelson JE; Kinan D; Stewart D; Yusuf S; Smith JJ; Kilcoyne L; Dolan N; Edens TR; Metherall J; Konstam MA
Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
[TBL] [Abstract][Full Text] [Related]
32. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
[TBL] [Abstract][Full Text] [Related]
33. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
Greenberg B; Quinones MA; Koilpillai C; Limacher M; Shindler D; Benedict C; Shelton B
Circulation; 1995 May; 91(10):2573-81. PubMed ID: 7743619
[TBL] [Abstract][Full Text] [Related]
34. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
[TBL] [Abstract][Full Text] [Related]
35. Congestive heart failure: new therapeutic strategies.
Pitt B
Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
[TBL] [Abstract][Full Text] [Related]
36. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.
Dries DL; Exner DV; Domanski MJ; Greenberg B; Stevenson LW
J Am Coll Cardiol; 2000 Mar; 35(3):681-9. PubMed ID: 10716471
[TBL] [Abstract][Full Text] [Related]
37. Reduced mortality and morbidity with the use of angiotensin-converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
Yusuf S
Herz; 1993 Dec; 18 Suppl 1():444-8. PubMed ID: 8125425
[TBL] [Abstract][Full Text] [Related]
38. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
; Yusuf S; Pitt B; Davis CE; Hood WB; Cohn JN
N Engl J Med; 1992 Sep; 327(10):685-91. PubMed ID: 1463530
[TBL] [Abstract][Full Text] [Related]
39. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators.
Benedict CR; Francis GS; Shelton B; Johnstone DE; Kubo SH; Kirlin P; Nicklas J; Liang CS; Konstam MA; Greenberg B
Am J Cardiol; 1995 Jun; 75(16):1151-7. PubMed ID: 7762503
[TBL] [Abstract][Full Text] [Related]
40. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
